What are the major opportunities in the Oncology Precision Medicine market? What are the strategies for the Oncology Precision Medicine market?

For detailed insights on the major opportunities and strategies in the Oncology Precision Medicine market, Read More

How does the Oncology Precision Medicine market relate to the overall economy and other similar markets?

For detailed insights on Oncology Precision Medicine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Oncology Precision Medicine market growth? SWOT analysis of the Oncology Precision Medicine market.

For detailed insights on the key dynamics influencing the Oncology Precision Medicine market growth and SWOT analysis of the Oncology Precision Medicine industry, Read More

Oncology Precision Medicine Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Oncology Precision Medicine Market Report 2026

Name: Oncology Precision Medicine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs), By Technology (Genomics, Proteomics, Bioinformatics, Other Technologies), By Biomarker Types (Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types), By Applications (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications), By End-Users (Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Oncology Precision Medicine Market Overview

• Oncology Precision Medicine market size has reached to $125.14 billion in 2025

• Expected to grow to $226.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%

• Growth Driver: The Growing Prevalence Of Cancer Is Enhancing The Market Growth Due To Aging Populations

• Market Trend: Advancing Personalized Cancer Care Through Collaborative Technology And Multidisciplinary Expertise

• North America was the largest region in 2025.

What Is Covered Under Oncology Precision Medicine Market?

Oncology precision medicine refers to a personalized approach to cancer care that uses genetic, molecular, and clinical information to tailor treatment strategies to the individual characteristics of each patient’s tumor. It aims to improve outcomes by selecting therapies that specifically target the unique biological features of a patient’s cancer, leading to more effective and less toxic treatments.

The main product types in oncology precision medicine are diagnostics, therapeutics, inhibitor drugs, monoclonal antibodies, cell and gene therapy, and antiviral and anti-retroviral drugs. Diagnostics is the process of identifying diseases or medical conditions through examination, testing, and analysis of symptoms or samples. The key technologies are genomics, proteomics, bioinformatics, and others. Different biomarker types are genetic biomarkers, protein biomarkers, epigenetic biomarkers, metabolic biomarkers, and others. The various applications involved are breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, kidney cancer, liver cancer, bladder cancer, and others, and they are used by several end users such as hospitals, diagnostic laboratories, research institutions, pharmaceutical companies, and others.

Oncology Precision Medicine Market Global Report 2026 Market Report bar graph

What Is The Oncology Precision Medicine Market Size and Share 2026?

The oncology precision medicine market size has grown rapidly in recent years. It will grow from $125.14 billion in 2025 to $141.22 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to limited availability of genomic testing, reliance on standard chemotherapy protocols, increasing cancer prevalence, early development of molecular diagnostics, adoption of hospital-based oncology research programs.

What Is The Oncology Precision Medicine Market Growth Forecast?

The oncology precision medicine market size is expected to see rapid growth in the next few years. It will grow to $226.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to advancements in CAR-T and gene therapies, growth in targeted kinase and immune checkpoint inhibitors, rising investments in precision oncology research, integration of bioinformatics and AI in clinical decision-making, expansion of biomarker-guided clinical trials. Major trends in the forecast period include rising adoption of personalized cancer therapies, increasing use of companion diagnostics and molecular diagnostics, growth in liquid biopsy and next-generation sequencing assays, expansion of targeted therapeutics and monoclonal antibodies, increasing focus on biomarker-based patient stratification.

Book your 30 minutes free consultation with our research experts

Global Oncology Precision Medicine Market Segmentation

1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs

2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies

3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types

4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications

5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays

2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies

5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies

6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers

What Is The Driver Of The Oncology Precision Medicine Market?

The growing prevalence of cancer is expected to propel the growth of the oncology precision medicine market going forward. Cancer is a disease in which abnormal cells grow uncontrollably and can spread to other parts of the body, disrupting normal bodily functions. The growing prevalence of cancer is due to aging populations, as prolonged lifespans lead to the accumulation of deoxyribonucleic acid (DNA) mutations, diminished repair systems, chronic inflammaging, weakening immune surveillance, and tissue microenvironments that increasingly support tumor growth. Oncology precision medicine is useful for cancer by providing personalized treatments based on the unique genetic makeup of each tumor, improving effectiveness and reducing side effects. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the estimated 20 million new cases of cancer in 2022 are expected to rise by 77% to over 35 million cases in 2050. Therefore, the growing prevalence of cancer is driving the growth of the oncology precision medicine industry.

Key Players In The Global Oncology Precision Medicine Market

Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.

Global Oncology Precision Medicine Market Trends and Insights

Major companies operating in the oncology precision medicine market are focusing on developing innovative solutions, such as molecular tumor board initiatives, to facilitate multidisciplinary collaboration and optimize personalized treatment planning. Molecular tumor boards are multidisciplinary teams of experts who review and interpret complex genetic and molecular test results to recommend personalized cancer treatment strategies. For instance, in April 2025, McKesson Corporation, a US-based healthcare services and information technology company, launched the Precision Care Companion initiative to support biomarker-driven cancer care by providing education, technology enhancements, and operational assistance to oncology practices. This comprehensive program brings together physicians, clinical staff, business leaders, and pharmaceutical partners to create a collaborative environment that speeds the integration of advanced genomic testing and targeted therapies, ultimately helping providers deliver more personalized and effective cancer treatments while improving patient outcomes.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Oncology Precision Medicine Market?

In February 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired Immunogen for $10.1 billion. Through this acquisition, AbbVie aims to accelerate its entry into the solid tumor space and enhance its oncology portfolio by leveraging Immunogen’s commercial infrastructure, established global reach, and promising antibody drug conjugate pipeline beyond ovarian cancer. ImmunoGen Inc. is a US-based biotechnology company that provides antibody-drug conjugates that deliver precision-targeted therapies for treating cancer based on specific tumor biomarkers.

Regional Insights

North America was the largest region in the oncology precision medicine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oncology Precision Medicine Market?

The oncology precision medicine market consists of revenues earned by entities by providing services such as personalized treatment planning, molecular tumor profiling services, companion diagnostics services, clinical decision support services, and patient risk assessment and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The oncology precision medicine market also includes sales of next-generation sequencing (NGS) machines, polymerase chain reaction (PCR) systems, flow cytometers, and robotic sample preparation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncology Precision Medicine Market Report 2026?

The oncology precision medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology precision medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Oncology Precision Medicine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$141.22 billion
Revenue Forecast In 2035	$226.55 billion
Growth Rate	CAGR of 12.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Technology, Biomarker Types, Applications, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories In
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oncology Precision Medicine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oncology Precision Medicine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oncology Precision Medicine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oncology Precision Medicine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Personalized Cancer Therapies

4.2.2 Increasing Use Of Companion Diagnostics And Molecular Diagnostics

4.2.3 Growth In Liquid Biopsy And Next-Generation Sequencing Assays

4.2.4 Expansion Of Targeted Therapeutics And Monoclonal Antibodies

4.2.5 Increasing Focus On Biomarker-Based Patient Stratification

5. Oncology Precision Medicine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Research Institutions

5.4 Pharmaceutical Companies

5.5 Cancer Treatment Centers

6. Oncology Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Precision Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oncology Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oncology Precision Medicine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oncology Precision Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oncology Precision Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Precision Medicine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Precision Medicine Market Segmentation

9.1. Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs

9.2. Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genomics, Proteomics, Bioinformatics, Other Technologies

9.3. Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types

9.4. Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications

9.5. Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users

9.6. Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays

9.7. Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

9.8. Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.9. Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies

9.10. Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies

9.11. Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers

10. Oncology Precision Medicine Market Regional And Country Analysis

10.1. Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Precision Medicine Market

11.1. Asia-Pacific Oncology Precision Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Precision Medicine Market

12.1. China Oncology Precision Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Precision Medicine Market

13.1. India Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Precision Medicine Market

14.1. Japan Oncology Precision Medicine Market Overview

14.2. Japan Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Precision Medicine Market

15.1. Australia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Precision Medicine Market

16.1. Indonesia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Precision Medicine Market

17.1. South Korea Oncology Precision Medicine Market Overview

17.2. South Korea Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncology Precision Medicine Market

18.1. Taiwan Oncology Precision Medicine Market Overview

18.2. Taiwan Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncology Precision Medicine Market

19.1. South East Asia Oncology Precision Medicine Market Overview

19.2. South East Asia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncology Precision Medicine Market

20.1. Western Europe Oncology Precision Medicine Market Overview

20.2. Western Europe Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncology Precision Medicine Market

21.1. UK Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncology Precision Medicine Market

22.1. Germany Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncology Precision Medicine Market

23.1. France Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncology Precision Medicine Market

24.1. Italy Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncology Precision Medicine Market

25.1. Spain Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncology Precision Medicine Market

26.1. Eastern Europe Oncology Precision Medicine Market Overview

26.2. Eastern Europe Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncology Precision Medicine Market

27.1. Russia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncology Precision Medicine Market

28.1. North America Oncology Precision Medicine Market Overview

28.2. North America Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncology Precision Medicine Market

29.1. USA Oncology Precision Medicine Market Overview

29.2. USA Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncology Precision Medicine Market

30.1. Canada Oncology Precision Medicine Market Overview

30.2. Canada Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncology Precision Medicine Market

31.1. South America Oncology Precision Medicine Market Overview

31.2. South America Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncology Precision Medicine Market

32.1. Brazil Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncology Precision Medicine Market

33.1. Middle East Oncology Precision Medicine Market Overview

33.2. Middle East Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncology Precision Medicine Market

34.1. Africa Oncology Precision Medicine Market Overview

34.2. Africa Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncology Precision Medicine Market Regulatory and Investment Landscape

36. Oncology Precision Medicine Market Competitive Landscape And Company Profiles

36.1. Oncology Precision Medicine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oncology Precision Medicine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oncology Precision Medicine Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Oncology Precision Medicine Market Other Major And Innovative Companies

Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc

38. Global Oncology Precision Medicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncology Precision Medicine Market

40. Oncology Precision Medicine Market High Potential Countries, Segments and Strategies

40.1 Oncology Precision Medicine Market In 2030 - Countries Offering Most New Opportunities

40.2 Oncology Precision Medicine Market In 2030 - Segments Offering Most New Opportunities

40.3 Oncology Precision Medicine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Oncology Precision Medicine Market, Overview Of Key Products - Product Examples

Table 2: Global Oncology Precision Medicine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Oncology Precision Medicine Market, Supply Chain Analysis

Table 4: Global Oncology Precision Medicine Market, Major Raw Material Providers

Table 5: Global Oncology Precision Medicine Market, Major Resource Providers

Table 6: Global Oncology Precision Medicine Market, Major Manufacturers (Suppliers)

Table 7: Global Oncology Precision Medicine Market, Major Distributors And Channel Partners

Table 8: Global Oncology Precision Medicine Market, Key Technologies & Future Trends

Table 9: Global Oncology Precision Medicine Market, Major Trends

Table 10: Global Oncology Precision Medicine Market, Major End Users

Table 11: Global Oncology Precision Medicine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Oncology Precision Medicine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Oncology Precision Medicine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Oncology Precision Medicine Market - TAM, US$ Billion, 2025

Table 15: Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Global Oncology Precision Medicine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 101: Global Oncology Precision Medicine Market - Company Scoring Matrix

Table 102: Roche Holding AG Financial Performance

Table 103: Bristol Myers Squibb Company Financial Performance

Table 104: Abbott Laboratories Financial Performance

Table 105: Novartis AG Financial Performance

Table 106: Gilead Sciences Inc. Financial Performance

Table 107: Global Oncology Precision Medicine Market, Competitive Benchmarking (In USD Billions)

Table 108: Global Oncology Precision Medicine Market, Competitive Dashboard

Table 109: Global Oncology Precision Medicine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 110: Global, Oncology Precision Medicine Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 111: Global, Oncology Precision Medicine Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 112: Global, Oncology Precision Medicine Market Size Gain ($ Billion), Segmentation By Biomarker Types, 2025 – 2030

List Of Figures

Figure 1: Global Oncology Precision Medicine Market, Overview Of Key Products - Product Examples

Figure 2: Global Oncology Precision Medicine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Oncology Precision Medicine Market, Supply Chain Analysis

Figure 4: Global Oncology Precision Medicine Market, Major Raw Material Providers

Figure 5: Global Oncology Precision Medicine Market, Major Resource Providers

Figure 6: Global Oncology Precision Medicine Market, Major Manufacturers (Suppliers)

Figure 7: Global Oncology Precision Medicine Market, Major Distributors And Channel Partners

Figure 8: Global Oncology Precision Medicine Market, Key Technologies & Future Trends

Figure 9: Global Oncology Precision Medicine Market, Major Trends

Figure 10: Global Oncology Precision Medicine Market, Major End Users

Figure 11: Global Oncology Precision Medicine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Oncology Precision Medicine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Oncology Precision Medicine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Oncology Precision Medicine Market - TAM, US$ Billion, 2025

Figure 15: Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Global Oncology Precision Medicine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 101: Global Oncology Precision Medicine Market - Company Scoring Matrix

Figure 102: Roche Holding AG Financial Performance

Figure 103: Bristol Myers Squibb Company Financial Performance

Figure 104: Abbott Laboratories Financial Performance

Figure 105: Novartis AG Financial Performance

Figure 106: Gilead Sciences Inc. Financial Performance

Figure 107: Global Oncology Precision Medicine Market, Competitive Benchmarking (In USD Billions)

Figure 108: Global Oncology Precision Medicine Market, Competitive Dashboard

Figure 109: Global Oncology Precision Medicine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 110: Global, Oncology Precision Medicine Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 111: Global, Oncology Precision Medicine Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 112: Global, Oncology Precision Medicine Market Size Gain ($ Billion), Segmentation By Biomarker Types, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Clinical Oncology Next Generation Sequencing Market Report 2026 - Global Outlook – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible...

Oncology Devices Market Report 2026 - Global Outlook – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hosp...

Oncology Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,...

Oncology Information Systems Market Report 2026 - Global Outlook – By Product (Solutions, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology), By End User (Hospitals And Diagn...

Generic Oncology Drugs Market Report 2026 - Global Outlook – By Molecule Type (Large Molecule, Small Molecule), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, ...

Precision Medicine Market Report 2026 - Global Outlook – By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology), By Application (Oncology, Respiratory...

Frequently Asked Questions

How big is the Oncology Precision Medicine Market?

The Oncology Precision Medicine market was valued at $125.14 billion in 2025, increased to $141.22 billion in 2026, and is projected to reach $226.55 billion by 2030.

What is the Oncology Precision Medicine market growth?

The global Oncology Precision Medicine market is expected to grow at a CAGR of 12.5% from 2026 to 2035 to reach $226.55 billion by 2035.

Who are the key players in Oncology Precision Medicine market?

Some Key Players in the Oncology Precision Medicine market Include, Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc. .

What is the anticipated growth trend for the Oncology Precision Medicine market?

Major trend in this market includes: Advancing Personalized Cancer Care Through Collaborative Technology And Multidisciplinary Expertise. For further insights on this market. request a sample here

Which region has the most growth potential in the Oncology Precision Medicine market?

North America was the largest region in the oncology precision medicine market in 2025. The regions covered in the oncology precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.